Clinical Characteristics and Cytogenetics of Childhood Acute Lymphoblastic Leukemia in a Single Center in Pakistan

被引:0
作者
Tabassum, Najia [1 ]
Muhammad, Sadia [2 ]
Mirza, Talat [3 ]
Butt, Zainab [2 ]
Mansoor, Neelum [2 ]
机构
[1] Ziauddin Med Coll, Karachi, Pakistan
[2] Indus Hosp, Karachi, Pakistan
[3] Ziauddin Univ, Karachi, Pakistan
关键词
acute lymphoblastic leukemia; cytogenetics; BCR::ABL1; ETV6::RUNX1; KMT2A; CHILDREN; DIAGNOSIS;
D O I
10.1177/2333794X241256863
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives. This study aimed to find the association between clinical characteristics, cytogenetics, and post-induction outcomes of childhood acute lymphoblastic leukemia. Methods. The study was conducted at the Indus Hospital in Karachi. Initial total leukocyte count (TLC), cytogenetics, CNS status, and post-induction remission status were recorded. Results. Out of 108 children diagnosed with ALL, 66 (61.1%) were male and 42 (38.9%) were female. The majority 90 (83.3%) had B-ALL. CNS1 status was observed in 76 (84.4%) B-ALL and 18 (88.9%) T-ALL. All T-ALL and 89 (98.8%) B-ALL achieved remission post-induction. In B-ALL, 50 (55.5%) had a normal diploid karyotype, and 22 (24.4%) had numerical abnormalities. No typical gene rearrangement was observed in 66 (73.3%), 11 (12.2%) had BCR::ABL1, 10 (11.1%) had ETV6::RUNX1 and 3 (3.3%) KMT2A on FISH. No significant difference was observed between cytogenetics and clinical characteristics (P > .05). Conclusion. The study provides valuable data on childhood acute lymphoblastic leukemia in the Pakistani population.
引用
收藏
页数:9
相关论文
共 42 条
[41]   Quantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia [J].
West, Zachary E. ;
Castellino, Sharon M. ;
Monroe, Caitlin ;
Thomas, Amanda S. ;
McCracken, Courtney ;
Miller, Tamara P. .
LEUKEMIA & LYMPHOMA, 2021, 62 (04) :899-908
[42]   A 9-gene score for risk stratification in B-cell acute lymphoblastic leukemia [J].
Yan, Feng ;
Wong, Nicholas C. ;
Powell, David R. ;
Curtis, David J. .
LEUKEMIA, 2020, 34 (11) :3070-3074